Accordingly, specific medications can be selected based on the patient’s condition; for example, IL-1β is related to myocardial infarction, and downregulating its concentration with the demethylase Jmjd3 can improve post-infarction depression [93]. Here, IL1B is linked to depressive symptom measurement.